ampicillin has been researched along with avibactam in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bayer, A; Christopeit, T; Guttormsen, Y; Leiros, HK; Lund, BA | 1 |
| Bonomo, RA; Papp-Wallace, KM; Taracila, MA; Winkler, ML | 2 |
| Echols, R; Gill, CM; Longshaw, C; Nicolau, DP; Santini, D; Takemura, M; Yamano, Y | 1 |
| Aguirre García, MA; Bitter, W; Kuijl, CP; Maaskant, JJ; Meijer, AH; Ubbink, M; van Alen, I | 1 |
5 other study(ies) available for ampicillin and avibactam
| Article | Year |
|---|---|
Screening and Design of Inhibitor Scaffolds for the Antibiotic Resistance Oxacillinase-48 (OXA-48) through Surface Plasmon Resonance Screening.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship; Surface Plasmon Resonance | 2016 |
Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam.
Topics: Acylation; Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Ceftazidime; Crystallography, X-Ray; Drug Combinations; Escherichia coli; Microbial Sensitivity Tests; Models, Molecular; Molecular Dynamics Simulation | 2015 |
Avibactam and inhibitor-resistant SHV β-lactamases.
Topics: Acylation; Ampicillin; Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; Catalytic Domain; Ceftazidime; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Microbial Sensitivity Tests; Models, Molecular | 2015 |
In vivo efficacy & resistance prevention of cefiderocol in combination with ceftazidime/avibactam, ampicillin/sulbactam or meropenem using human-simulated regimens versus Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Ampicillin; Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Cefiderocol; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Meropenem; Mice; Microbial Sensitivity Tests; Sulbactam | 2023 |
Mycobacterium tuberculosis β-lactamase variant reduces sensitivity to ampicillin/avibactam in a zebrafish-Mycobacterium marinum model of tuberculosis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; beta-Lactamases; Escherichia coli; Mycobacterium marinum; Mycobacterium tuberculosis; Tuberculosis; Zebrafish | 2023 |